Hyaluronic Acid
Hyaluronic Acid (sodium hyaluronate) is a glycosaminoglycan naturally found in skin, joints, and connective tissue. In gummy formats it is most commonly used in beauty and nutricosmetics ranges for skin hydration and elasticity, often paired with Collagen and Vitamin C. HA itself has no authorised EU health claim under Reg. 432/2012; claim coverage derives from co-formulated nutrients.
Where this ingredient fits in the DAT Supply catalogue
Every format chip links through to its manufacturing hub . The category chip routes to the matching vertical hub on the categories index.
- Beauty & skin
- Browse all ingredients
Why brands use Hyaluronic Acid
Hyaluronic Acid is a formulation input reviewed per project, sitting in the functional compounds family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only applicable claims framework- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Hyaluronic Acid for gummies, capsule, softgel, powder and drops; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — no two briefs land on the same combination, and we don’t publish off-the-shelf doses.
Formats this ingredient is reviewed for
DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.
Format suitability reviewed per project.
Formulation notes
Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.
- Heat stable
- Limited — use coated forms
- Soluble in matrix
- Conditional
- Vegan supply
- Project-specific
Per-format formulation notes
Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.
Gummies
In a pectin- or gelatin-based gummy matrix, Hyaluronic Acid is reviewed for heat stability through the cooking step, dispersibility across the dosed mass, and any flavour interaction with the cooked base. Coated or encapsulated forms may be considered when the raw active would shift taste or colour outside the target window. Per-gummy payload, daily serving count and the resulting label claim are tuned against the brand’s pack architecture. Pectin and gelatin behave differently for moisture migration and shelf-life — the matrix choice is reviewed per project alongside the active’s sensitivity to acidity, light and oxygen. Where a high inclusion rate would compromise gummy texture, we split the load across two pieces or move to a denser format. Final dosing and matrix selection are confirmed per project.
Capsules
In a two-piece capsule format Hyaluronic Acid is reviewed for fit against the chosen capsule size, the blend’s bulk density and flow, and any excipient set needed for stable filling. Shell choice (gelatin vs HPMC for vegan ranges) is tuned against the active’s moisture sensitivity and the brand’s diet positioning. Capsules carry medium-to-high payloads and let the brand split a multi-active stack across one or two daily servings, with the daily serving count reviewed per project. Where the active is hygroscopic or has a strong odour, we may pre-coat or granulate before filling. Final excipient set, capsule size and per-serving load are confirmed per project.
Softgels
In a softgel format Hyaluronic Acid must be oil-soluble or oil-dispersible; water-loving actives sit on the gummy or capsule route instead. The fill carrier (a refined oil or a co-solubilising system) is reviewed against the active’s oxidation profile and shelf-life targets, with antioxidant load tuned where the active is prone to oxidation. Shell choice (gelatin vs non-gelatin for vegan ranges) is set against the brand’s diet positioning, and the shell-fill interaction is reviewed for water migration. Softgel size and per-piece fill weight are tuned against the target dose — reviewed per project alongside the brand’s daily serving plan and pack format.
Powders
In a powder format Hyaluronic Acid is reviewed for flow, bulk density and blend uniformity, plus dispersibility and taste on reconstitution. Hygroscopic actives may need a desiccant, a moisture-barrier pouch, or an aluminium-laminate tub liner. Powder lets the brand carry the highest per-serving payloads of any DAT format, which can suit collagen-, protein- or electrolyte-positioned ranges. Pack format (tub, sachet, stick) is set against the daily serving plan and the brand’s shopper context — at-home tubs vs on-the-go sticks. Particle size, sweetener / acidulant balance and any flow aid are tuned per project to land the target sensory window.
Liquid drops
In a liquid-drop format Hyaluronic Acid must be soluble or stably dispersible in the chosen carrier (water, glycerin, oil or a mixed system). Taste masking, preservation, pH window and shelf-life targets are reviewed against the active’s sensitivity profile. Bottle and dropper geometry are matched to the target per-drop dose, with serving accuracy validated through the dropper’s drop-volume specification. Liquids carry sensitive actives well but require a tighter shelf-life and packaging plan than dry formats. Where the active is light-sensitive, amber glass or barrier-tinted PET is reviewed against the run plan. Preservation system and pH are set per project.
US structure-function statements
Structure-function wording for this ingredient is reviewed per project against DSHEA (21 USC §343(r)(6)). No final on-pack copy is implied by this page.
Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Claim framework
Hyaluronic Acid is reviewed against the target market’s claim posture: applicable claims framework wording (UK tracks EU post-Brexit) for the EU/UK route, and DSHEA structure-function wording with the FDA disclosure for the US route. Pack copy is rewritten per market and confirmed per project.
Typical anchor: mg per serving — confirmed per project.
Hyaluronic Acid is measured by weight (mg) per serving on DAT Supply briefs. The working anchor — the inclusion rate against which target-market claim wording is reviewed — is set during the formulation pass for each project rather than published as a fixed number on the public page. Final per-serving load depends on the chosen format (gummy payload window, capsule fill weight, softgel oil load, sachet or powder scoop size, oral-liquid bottle geometry) and the claim wording the brand needs to support against the target market. Sourcing form (extract ratio, standardised marker, micronised vs granular, salt or chelate form) is reviewed in the same pass. Country-level upper limits (France, Italy, Belgium for the EU; California Prop 65 for the US) are checked before any inclusion rate is finalised. Dose is confirmed per project — we don’t publish off-the-shelf dose tables for any active in the catalogue.
Product concepts featuring Hyaluronic Acid
Private-label product concepts where Hyaluronic Acid appears in the formula. Each opens to a product brief and quote route.
Hyaluronic Glow Gummies
Private label hyaluronic glow gummies for supplement brands. Pectin-based, target-market reviewed manufacturing.
Radiance & Youth Gummies
Private label radiance & youth gummies for supplement brands. Pectin-based, target-market reviewed manufacturing.
Sleep & Skin Recovery Gummies
Private label sleep & skin recovery gummies for supplement brands. Pectin-based, target-market reviewed manufacturing.
Similar ingredients
Ingredients that frequently sit alongside this one in private-label supplement briefs.
Chondroitin Sulfate
Chondroitin sulfate is a naturally occurring glycosaminoglycan found in cartilage and connective tissue. It is one of the most familiar and commercially understood joint health actives across EU and US markets. Chondroitin sulfate has no authorised health claims under Reg. (EU) 432/2012, so brands typically position it alongside co-formulated nutrients such as Vitamin C (for collagen formation) or Vitamin D (for normal bone function). It is not suitable for gummy formats due to poor solubility and high molecular weight, and is typically delivered in sachet formats.
Dihydroberberine
Dihydroberberine is a reduced form of berberine, a naturally occurring alkaloid found in plants such as Berberis aristata and Coptis chinensis. It is used in dietary supplements for metabolic wellness and blood sugar balance positioning. As a botanical-derived compound on the EU on-hold list, it has no authorised health claims under Reg. (EU) 432/2012.
Glucosamine Sulfate
Glucosamine is a naturally occurring amino sugar that is a structural component of cartilage and synovial fluid. In supplement form (sulfate or hydrochloride), it has been used for decades in joint-positioned ranges. Glucosamine itself has no authorised EU health claim under Reg. 432/2012; in gummy formats it is most commonly positioned for 'joint comfort' alongside co-formulated nutrients that carry authorised claims.
Lutein
Lutein is a carotenoid pigment found naturally in green leafy vegetables and egg yolks. It is one of the most familiar and commercially understood gummy actives across EU and US markets, primarily positioned for eye and macular health. Lutein has no authorised health claim under Reg. (EU) 432/2012; any claim coverage relies on co-formulated nutrients.
Melatonin
Melatonin is a hormone naturally produced by the pineal gland that regulates circadian rhythm and sleep onset. In food-supplement gummy formats it is the most commonly requested sleep-onset active, with two EU-authorised health claims under Reg. 432/2012 at 1 mg (sleep onset) and 0.5 mg (jet lag) per portion. Above these doses, EU classification typically shifts to medicinal product — Member State verification is required per project.
NMN
NMN (nicotinamide mononucleotide) is a nucleotide derivative and a direct precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme central to cellular energy metabolism and DNA repair. In the EU, NMN is currently under novel food assessment and does not carry authorised health claims under Reg. (EU) 432/2012. Brands use NMN for healthy-ageing and cellular-energy positioning in markets where it is permitted (UK, US, and select non-EU markets).
Adjacent reading
Pairings, resource guides and blog notes most often associated with Hyaluronic Acid on DAT Supply briefs.
Ready to start your order?
Create your account, complete your company profile and brief your order inside the DAT Supply portal — samples, formulas, packaging and documentation in one client workspace.